Analyst firms · Jefferies · ABVX
Jefferies ABVX price target and rating history
Abivax SA (ABVX) · Health Care
Jefferies rates Abivax SA (ABVX) Buy with a $158 price target, as of its latest action on Jul 1, 2026. It has published 3 rating actions on ABVX since March 2026, including 1 upgrade and 1 downgrade.
- Current rating
- Buy
- Price target
- $158
- Median target, all firms
- Too few
- Actions on ABVX
- 3
Jefferies price target on ABVX
Every Jefferies rating on ABVX
- Jul 1, 2026
- Jun 2, 2026
- Mar 16, 2026
How other firms rate ABVX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Jefferies | Buy | $158 | Jul 1, 2026 |
| Wedbush | Neutral | $90 | Jun 2, 2026 |
| Truist Securities | Buy | Nov 24, 2025 |
Questions about Jefferies and ABVX
- What is Jefferies's price target for ABVX?
- Jefferies's latest stated price target for Abivax SA (ABVX) is $158, from its action on Jul 1, 2026.
- What is Jefferies's rating on ABVX?
- Jefferies rates ABVX Buy, a bullish rating, as of Jul 1, 2026.
- When did Jefferies last change its view on ABVX?
- On Jul 1, 2026, Jefferies upgrades to Buy from Hold, price target $158.
More ABVX rating histories
All Jefferies ratingsABVX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.